Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

FENC
Fennec Pharmaceuticals Inc. Common Stock
stock NASDAQ

At Close
Jun 9, 2025 3:59:51 PM EDT
8.26USD-2.017%(-0.17)76,322
8.28Bid   8.35Ask   0.07Spread
Pre-market
Jun 6, 2025 8:39:30 AM EDT
7.98USD-5.338%(-0.45)0
After-hours
Jun 9, 2025 4:00:30 PM EDT
8.25USD0.000%(0.00)1,290
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
06:19AM EST  Fennec Pharma's Chief Commercial Officer Shubh Goel To Depart In Late February   RTTNews
06:00AM EST  Fennec Pharmaceuticals Announces Management Change   GlobeNewswire Inc
Nov 30, 2021
04:21PM EST  Mid-Afternoon Market Update: Dow Jumps 300 Points; Krystal Biotech Shares Spike Higher   Benzinga
04:11PM EST  Mid-Day Market Update: Crude Oil Rises 4%; Fennec Pharmaceuticals Shares Slide   Benzinga
04:04PM EST  Mid-Morning Market Update: Markets Open Higher; Li Auto Sales Top Views   Benzinga
06:18AM EST  Fennec Pharmaceuticals Inc. (FENC) has received a Complete Response Letter from FDA regarding the company's New Drug Application for PEDMARK. The CRL was issued as a result of identified manufacturing deficiencies. Fennec plans to request a Type A meeting with the FDA.   RTTNews
06:07AM EST  Fennec Pharma Receives CRL From FDA For PEDMARK NDA Again   RTTNews
06:00AM EST  Fennec Pharmaceuticals Receives Complete Response Letter from the   GlobeNewswire Inc
Nov 29, 2021
07:24PM EST  Pomerantz LLP is investigating claims on behalf of investors of Fennec Pharmaceuticals Inc. (Fennec or the Company) (NASDAQ: FENC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
07:26AM EST  Fennec Pharmaceuticals Inc. (FENC) said on Monday that it expects to receive a Complete Response Letter from the FDA for its lead drug candidate Pedmark.   RTTNews
06:24AM EST  Fennec Pharma Expects To Receive CRL From FDA For PEDMARK NDA   RTTNews
06:07AM EST  Fennec Pharmaceuticals Expects To Receive Complete Response Letter From The FDA For Its New Drug Application For PEDMARK To Prevent Ototoxicity Associated With Cisplatin In Pediatric Patients With Localized, Non-Metastatic, Solid Tumors   Benzinga
06:00AM EST  Fennec Pharmaceuticals Expects to Receive Complete Response Letter   GlobeNewswire Inc
Nov 21, 2021
03:05PM EST  The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week   Benzinga
Nov 10, 2021
08:23AM EST  The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance   Benzinga
06:10AM EST  Fennec Pharmaceuticals Q3 EPS $(0.16) Up From $(0.24) YoY   Benzinga
06:05AM EST  Fennec Pharma Q3 Loss Per Share $0.16 Vs Loss $0.24 Last Year   RTTNews
06:00AM EST  ~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~~W0:   GlobeNewswire Inc
Sep 29, 2021
08:13AM EDT  The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug   Benzinga
Sep 9, 2021
06:00AM EDT  Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences   GlobeNewswire Inc
Aug 10, 2021
06:15AM EDT  Fennec Pharmaceuticals Q2 EPS $(0.15) Beats $(0.19) Estimate   Benzinga
06:12AM EDT  Fennec Pharma Q2 Net Loss $4.0 Mln Or $0.15/Shr Vs Loss $4.8 Mln Or $0.21/Shr Last Year   RTTNews
06:00AM EDT  ~ FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 ~~W0:   GlobeNewswire Inc
Jun 29, 2021
05:30PM EDT  Fennec Pharmaceuticals Inc. (the Company) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021.   GlobeNewswire Inc
Jun 24, 2021
06:13AM EDT  Fennec Pharma Amends Existing Senior Debt Facility With Life Sciences At Bridge Bank Increasing The Size To $20 Mln   RTTNews
06:00AM EDT  Fennec Pharmaceuticals Announces Amendment to Increase Existing   GlobeNewswire Inc
Jun 22, 2021
08:12AM EDT  The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal   Benzinga
07:17AM EDT  Fennec Pharma Stock Is Trading Higher As Pedmark Is Under FDA Review For Chemo-Induced Toxicity   Benzinga
06:32AM EDT  Fennec Pharma: FDA Accepts Filing The Resubmission Of NDA For PEDMARK   RTTNews
06:00AM EDT  Fennec Pharmaceuticals Announces FDA Acceptance Of New Drug Application Resubmission For PEDMARK   Benzinga
06:00AM EDT  ~ Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 27, 2021 00EF   GlobeNewswire Inc
Jun 3, 2021
06:13AM EDT  HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $14   Benzinga
May 28, 2021
08:34AM EDT  Fennec Pharma Refiles Pedmark US Application For Cisplatin-Induced Ototoxicity In Pediatric Patients   Benzinga
08:02AM EDT  The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq   Benzinga
06:31AM EDT  Fennec Pharmaceuticals Inc. (FENC) has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Pedmark for the prevention of ototoxicity induced by cisplatin chemotherapy in pediatric patients with localized, non-metastatic, solid tumors.   RTTNews
06:05AM EDT  Fennec Announces Resubmission Of NDA To FDA For PEDMARK   RTTNews
06:02AM EDT  Fennec Pharma Reports Resubmission Of New Drug Application For Its PEDMARK Treatment Candidate   Benzinga
06:00AM EDT  Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food   GlobeNewswire Inc
May 27, 2021
05:58PM EDT  First Horizon Corporation (NYSE:FHN) plans to announce second quarter 2021 financial results on July 16, 2021. The news release and supplemental materials will be available atir.fhnc.com at approximately 6:45 am ET/5:45 am CT. FHN management will host a live presentation that morning with details as follows:   GlobeNewswire Inc
May 13, 2021
06:17AM EDT  Fennec Pharmaceuticals Q1 EPS $(0.18) Up From $(0.19) YoY   Benzinga
06:00AM EDT  ~ Fennec Remains on Track to Finalize and Resubmit the New Drug Application for PEDMARKto the U.S. Food and Drug Administration in the Second Quarter of 2021 ~~W0:   GlobeNewswire Inc
Apr 21, 2021
01:59PM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021   Benzinga
09:26AM EDT  Craig-Hallum Initiates Coverage On Fennec Pharmaceuticals with Buy Rating, Announces Price Target of $17   Benzinga
Apr 19, 2021
10:06AM EDT  Maxim Group Initiates Coverage On Fennec Pharmaceuticals with Buy Rating, Announces Price Target of $12   Benzinga
Mar 30, 2021
06:02AM EDT  Fennec Pharmaceuticals Q4 EPS $(0.13) Up From $(0.18) YoY; Says Has ~$30M In Cash And No Outstanding Debt   Benzinga
06:00AM EDT  ~ Fennec is Working Closely with its Third-PartyDrug Product Manufacturer to Finalize the New Drug Application (NDA) Resubmission for PEDMARK~~W0:   GlobeNewswire Inc
Nov 16, 2020
07:19AM EST  Fennec Pharmaceuticals Q3 EPS $(0.24) Down From $(0.09) YoY   Benzinga
07:02AM EST  ~ The Company Continues to Work with the FDA and Its Third-Party Drug Product Manufacturer to Fully Address CRL and Prepare NDA Resubmission for PEDMARK~~W0:   GlobeNewswire Inc
Nov 1, 2020
03:46PM EST  FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Reminds Fennec   GlobeNewswire Inc
Oct 30, 2020
11:00AM EDT  FENC Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020   Business Wire
Oct 29, 2020
11:30AM EDT  FENC CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files a Securities   PR Newswire
Oct 28, 2020
07:35PM EDT  Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENC   PR Newswire
12:30PM EDT  Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)   PR Newswire
Oct 27, 2020
12:00PM EDT  UPLCQ, FENC & HDB Class Action Reminders: Bronstein, Gewirtz &   GlobeNewswire Inc
11:01AM EDT  Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class   PR Newswire
Oct 26, 2020
12:30PM EDT  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
11:00AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
10:26AM EDT  Only 7 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc.   PR Newswire
Oct 21, 2020
02:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
10:00AM EDT  UPLCQ, FENC & HDB Upcoming Deadlines: Bronstein, Gewirtz &   GlobeNewswire Inc
Oct 20, 2020
11:00AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
10:20AM EDT  FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors   GlobeNewswire Inc
Oct 16, 2020
06:39PM EDT  ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals   GlobeNewswire Inc
Oct 15, 2020
03:00PM EDT  ROSEN, A TOP RANKED LAW FIRM, Reminds Fennec Pharmaceuticals Inc.   GlobeNewswire Inc
11:30AM EDT  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Oct 14, 2020
03:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
10:14AM EDT  Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc.   PR Newswire
Oct 13, 2020
11:00AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Oct 12, 2020
12:00PM EDT  Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline   GlobeNewswire Inc
Oct 9, 2020
08:09PM EDT  the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FENC   PR Newswire
01:00PM EDT  Glancy Prongay & Murray Reminds Investors of Looming Deadline in   GlobeNewswire Inc
11:15AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Oct 7, 2020
05:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
12:30PM EDT  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
11:00AM EDT  FENC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm   Business Wire
Oct 3, 2020
01:00PM EDT  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact   PR Newswire
Oct 2, 2020
07:30PM EDT  ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc   GlobeNewswire Inc
01:00PM EDT  Glancy Prongay & Murray Reminds Investors of Looming Deadline in   GlobeNewswire Inc
Oct 1, 2020
11:30AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Sep 30, 2020
06:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
11:30AM EDT  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
10:33AM EDT  FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors   GlobeNewswire Inc
Sep 29, 2020
09:29AM EDT  Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc.   PR Newswire
Sep 25, 2020
05:45PM EDT  ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc   GlobeNewswire Inc
12:00PM EDT  FENC CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files a Securities   PR Newswire
Sep 24, 2020
11:30AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Sep 23, 2020
06:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
12:30PM EDT  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Sep 22, 2020
10:00AM EDT  FENC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds   GlobeNewswire Inc
Sep 21, 2020
12:30PM EDT  Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)   PR Newswire
09:21AM EDT  FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors   GlobeNewswire Inc
06:37AM EDT  Fennec Reports Issuance Of U.S. Patent For PEDMARK   RTTNews
06:06AM EDT  Fennec Announces Issuance Of US Patent For PEDMARK   Benzinga
Sep 18, 2020
11:00AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Sep 17, 2020
01:00PM EDT  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class   PR Newswire
Sep 16, 2020
07:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
Sep 14, 2020
05:24PM EDT  Lawsuit Against Fennec Pharmaceuticals Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FENC   PR Newswire
Sep 11, 2020
10:00AM EDT  FENC Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds   GlobeNewswire Inc
09:11AM EDT  FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc.   Business Wire
Sep 10, 2020
06:45PM EDT  ROSEN, A RESPECTED AND LEADING LAW FIRM, Reminds Fennec   GlobeNewswire Inc
01:50PM EDT  FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Fennec Pharmaceuticals Inc.   Business Wire
11:15AM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Sep 9, 2020
09:00PM EDT  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
11:00AM EDT  Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm   PR Newswire
08:00AM EDT  Portnoy Law: Lawsuit Filed On Behalf of Fennec Pharmaceuticals Inc   GlobeNewswire Inc
Sep 8, 2020
03:43PM EDT  FENNEC PHARMACEUTICALS, INC. CLASS ACTION ALERT: Wolf Haldenstein   GlobeNewswire Inc
Sep 4, 2020
04:00PM EDT  FENNEC ALERT: Bragar Eagel & Squire, P.C. Announces That a Class   GlobeNewswire Inc
11:32AM EDT  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has   GlobeNewswire Inc
Sep 3, 2020
05:28PM EDT  FENC CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Fennec Pharmaceuticals Inc.   Business Wire
Aug 18, 2020
04:35PM EDT  Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) resulting from allegations that Fennec may have issued materially misleading business information to the investing public.   GlobeNewswire Inc
Aug 17, 2020
09:00PM EDT  The law firm of Kirby McInerney LLP is investigating potential claims against Fennec Pharmaceuticals Inc. (Fennec or the Company) (NASDAQ: FENC). The investigation concerns whether Fennec and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.   GlobeNewswire Inc
Aug 15, 2020
10:35PM EDT  Pomerantz LLP is investigating claims on behalf of investors of Fennec Pharmaceuticals Inc. (Fennec or the Company) (NASDAQ:FENC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980.   GlobeNewswire Inc
Aug 13, 2020
09:47PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of   PR Newswire
Aug 12, 2020
06:00AM EDT  Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences   GlobeNewswire Inc
Aug 11, 2020
02:40PM EDT  Mid-Afternoon Market Update: Dow Rises 1%; Kforce Shares Climb On Upbeat Q2 Results   Benzinga
12:11PM EDT  Mid-Day Market Update: Gold Plunges Over 4%; Pfenex Shares Spike Higher   Benzinga
10:30AM EDT  Mid-Morning Market Update: Markets Mostly Higher; SYSCO Reports Q2 Loss   Benzinga
06:22AM EDT  Fennec Pharmaceuticals Receives Complete Response Letter From FDA For PEDMARK NDA; Says 'FDA Pre-Approval Inspection has Identified Deficiencies with the Facility of the Drug Product Manufacturer, which Require Resolution Prior to PEDMARK Approval'   Benzinga
06:12AM EDT  Fennec Pharma Receives CRL From FDA For PEDMARK To Prevent Ototoxicity Associated With Cisplatin   RTTNews
06:04AM EDT  ~ No Clinical Safety or Efficacy Issues Identified, and No Requirement for Further Clinical Data ~~W0:   GlobeNewswire Inc
Aug 10, 2020
05:56AM EDT  Fenc Pharma Shares Up 10% Premarket Ahead of Expected FDA Decision on Pedmark for Cisplatin-Induced Hearing Loss   Benzinga
Aug 5, 2020
06:00AM EDT  ~ FDA Set a PDUFA Target Action Date for PEDMARKTM of August 10, 2020 ~~W0:~ Strong Financial Position with $38.7 million in cash and no debt ~~W0:   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC